Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 20 Vitamin D Deficiency 19 Prostatic Neoplasms 14 Polycystic Ovary Syndrome 10 Neoplasms 8 Colonic Neoplasms 8 Rectal Neoplasms 6 Osteoporosis 5 Myelodysplastic Syndromes 5 Colorectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Cardiovascular Diseases 4 Warts 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Brain Neoplasms 3 Adenomatous Polyps 3 Pathologic Processes 2 Pain 2 Obesity 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Melanoma 2 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Insulin Resistance 2

Interventions

pembrolizumab 76 Gemcitabine 48 Nivolumab 41 Cisplatin 35 atezolizumab 34 Carboplatin 27 avelumab 25 enfortumab vedotin 23 Docetaxel 22 Magnetic Resonance Spectroscopy 17 Paclitaxel 15 Ipilimumab 15 Mitomycin 14 Specimen Handling 12 durvalumab 10 toripalimab 9 sacituzumab govitecan 9 Pemetrexed 8 vinflunine 7 cabozantinib 7 Taxes 7 Injections 6 Cyclophosphamide 6 Bevacizumab 6 tislelizumab 5 pemigatinib 5 Standard of Care 5 Fluorodeoxyglucose F18 5 Biopsy 5 lenvatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04197089 2022-08-03

VitDURO

Germans Trias i Pujol Hospital

Phase 4 Completed

Carcinoma, Transitional Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡